O'Malley Cynthia D, Prehn Angela W, Shema Sarah J, Glaser Sally L
Northern California Cancer Center, Union City, California 94587, USA.
Cancer. 2002 Jun 1;94(11):2836-43. doi: 10.1002/cncr.10521.
A rare occurrence, about 1500 men in the United States develop breast carcinoma each year. Little is known about survival patterns at the population level, particularly about racial/ethnic variation.
Using data from the Surveillance, Epidemiology, and End Results Program, we examined survival rates in 1979 men diagnosed with primary invasive breast carcinoma between 1973 and 1997. Race was defined as non-Hispanic white, non-Hispanic black, and other race/ethnicity (predominantly Asian/Pacific Islander and Hispanic). The two outcomes were all-cause and breast carcinoma- specific mortality. Survival curves were drawn using Kaplan-Meier estimates and Cox regression was used to estimate the risk of death with hazard ratios and 95% confidence intervals. For both outcomes, the racial/ethnic survival curves differed significantly when the log rank test was used. Therefore, separate models were run for each racial/ethnic group. Covariates included age, stage, histology, surgery, radiation therapy, and year of diagnosis. Estrogen and progesterone receptor status were available for 616 men.
Survival rates differed significantly by race/ethnicity. Overall, 5-year survival rates were 66% for whites, 57% for blacks, and 75% for men of other race/ethnicity. Blacks presented with more advanced disease. By stage, whites and blacks had worse survival rates compared with men of other race/ethnicity. The effects of prognostic factors such as age, surgery type, and radiation were similar, but not always significant, for all groups. Diagnosis year and estrogen receptor status did not affect survival.
Survival following male breast carcinoma differed by race/ethnicity, whereas the prognostic factors associated with survival were similar.
在美国,男性患乳腺癌是一种罕见情况,每年约有1500名男性罹患此病。在人群层面,对于其生存模式知之甚少,尤其是关于种族/族裔差异方面。
利用监测、流行病学和最终结果计划(Surveillance, Epidemiology, and End Results Program)的数据,我们研究了1973年至1997年间确诊为原发性浸润性乳腺癌的1979名男性的生存率。种族定义为非西班牙裔白人、非西班牙裔黑人以及其他种族/族裔(主要是亚裔/太平洋岛民和西班牙裔)。两个结局指标是全因死亡率和乳腺癌特异性死亡率。使用Kaplan-Meier估计法绘制生存曲线,并采用Cox回归来估计死亡风险,给出风险比和95%置信区间。对于这两个结局指标,当使用对数秩检验时,种族/族裔生存曲线存在显著差异。因此,针对每个种族/族裔群体分别运行模型。协变量包括年龄、分期、组织学类型、手术、放疗以及诊断年份。616名男性的雌激素和孕激素受体状态数据可用。
生存率因种族/族裔不同而有显著差异。总体而言,白人的5年生存率为66%,黑人为57%,其他种族/族裔的男性为75%。黑人所患疾病更为晚期。按分期来看,与其他种族/族裔的男性相比,白人和黑人的生存率更低。年龄、手术类型和放疗等预后因素对所有群体的影响相似,但并非总是显著。诊断年份和雌激素受体状态不影响生存。
男性乳腺癌患者的生存情况因种族/族裔而异,而与生存相关的预后因素相似。